Regulation of Advanced Therapy Medicinal Products: Concept Note and Recommendations. Ninth Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH). (San Salvador, October 2018)
Fecha
2019Número de documento
PAHO/HSS/19-004
Metadatos
Mostrar el registro completo del ítemOtros idiomas
Resumen
The aim of this document is to highlight the progress made with regard to advanced therapy products, the risks associated with such products, and the regulatory challenges they pose for Member States with a view to strengthening regulatory systems. The document is also a call to action for governments to consider the development of standards and rules for regulating these products in order to control the use of unapproved therapies and prevent risks to the population. As discussed, there are cross-cutting regulatory principles that should be implemented by any regulatory body that plans to undertake the regulation and oversight of advanced therapy products.
Tema
Categoría del Plan Estratégico 2014-2019 de la OPS
Cita
Pan American Health Organization. Regulation of Advanced Therapy Medicinal Products: Concept Note and Recommendations. Ninth Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH). (San Salvador, October 2018). Washington, D.C.: PAHO; 2019.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Etienne, Carissa F.; Califf, Robert (2016)Health regulation is regarded as one of public health’s basic functions. Effective regulation of medicines promotes and protects the public’s health by guaranteeing medicines quality, safety, and efficacy; promoting the ...
-
Centurión, Maria Pasionaria Blanco; Peres, Frederico; Moreira, Josino Costa; Jacob, Silvana do Couto (2023)[RESUMO]. O objetivo deste estudo descritivo e exploratório, de base qualitativa, foi identificar as resoluções do MERCOSUL sobre resíduos de agrotóxicos em alimentos publicadas entre 1991 e 2022, analisando os processos ...
-
Silva Júnior, João Batista; Costa, Christiane da Silva; Baccara, João Paulo de Araújo (2015)A utilização dos produtos do sangue como medicamentos essenciais e o reconhecimento das dimensões dos riscos transfusionais demandam dos países uma ação regulatória com foco em qualidade e segurança. Nesse campo, os órgãos ...